AGT and acute kidney injury: None of the outcomes were statistically significant, but authors found that patients in the angiotensin II group were more likely to achieve BP goals, had a shorter duration of vasopressor need, and had lower rates of acute kidney injury (AKI) and need for renal replacement therapy (RRT).